Dashboard
Manage Tickers

GDRXGoodRx Holdings, Inc.

Nasdaq goodrx.com


$ 6.73 $ 0.00 (0 %)    

Tuesday, 14-May-2024 10:54:22 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 444.10 $ -0.67 (-0.15 %)
DIA $ 394.70 $ -0.39 (-0.1 %)
SPY $ 521.63 $ -0.55 (-0.11 %)
TLT $ 90.64 $ 0.03 (0.03 %)
GLD $ 217.82 $ -0.02 (-0.01 %)
$ 6.7
$ 6.73
$ 6.72 x 106
$ 6.74 x 700
$ 6.70 - $ 6.74
$ 4.14 - $ 9.37
1,114,709
na
2.61B
$ 1.99
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-01-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-08-2022 06-30-2022 10-Q
9 05-09-2022 03-31-2022 10-Q
10 02-28-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-12-2021 06-30-2021 10-Q
13 05-14-2021 03-31-2021 10-Q
14 03-12-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

change-healthcare-cyberattack-goodrx-expects-low-single-digit-million-dollar-impact-in-2024
Change Healthcare Cyberattack: GoodRx Expe...
05/09/2024 18:24:19

GoodRx's Q1 earnings: $0.08 EPS, sales hit $197.88 million, beating expectations fueled by prescription transactions and ph...

goodrx-forecasts-2024-revenue-of-800m-810m-versus-consensus-of-85780m-with-adjusted-ebitda-over-250m
GoodRx Forecasts 2024 Revenue Of $800M-$81...
05/09/2024 10:54:24

goodrx-forecasts-q2-revenue-of-200m-versus-consensus-of-19957m-with--adjusted-ebitda-margin-in-low-thirty-percent-range
GoodRx Forecasts Q2 Revenue Of ~$200M Vers...
05/09/2024 10:52:07

goodrx-holdings-q1-2024-adj-eps-008-inline-sales-197880m-beat-196082m-estimate
GoodRx Holdings Q1 2024 Adj. EPS $0.08, In...
05/09/2024 10:07:01

goodrx-holdings-analyst-turns-bullish-ahead-of-q1-earnings
GoodRx Holdings Analyst Turns Bullish Ahea...
04/10/2024 16:10:47

GoodRx Holdings Inc (NASDAQ: GDRX) got an upgrade last month from Wells Fargo analyst.

keybanc-upgrades-goodrx-holdings-to-overweight-announces-9-price-target
Keybanc Upgrades GoodRx Holdings to Overwe...
04/10/2024 08:40:55

Keybanc analyst Scott Schoenhaus upgrades GoodRx Holdings (NASDAQ:GDRX) from Sector Weight to Overweight and announces $9 pr...

why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Landos Biopharma Shares Are Trading Hi...
03/25/2024 18:44:08

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

telemedicine-goodrx-has-potential-to-excel-close-valuation-gap-by-2025-analyst-says
Telemedicine GoodRx Has Potential To Excel...
03/25/2024 18:00:36

Wells Fargo's upgrade of GoodRx Holdings. Analysts anticipate strong revenue visibility and EBITDA margins, setting the sta...

the-latest-analyst-ratings-for-goodrx-holdings
The Latest Analyst Ratings For GoodRx Hold...
03/25/2024 15:00:13

esperion-therapeutics-masimo-and-other-big-stocks-moving-higher-in-mondays-pre-market-session
Esperion Therapeutics, Masimo And Other Bi...
03/25/2024 09:34:09

U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Th...

wells-fargo-upgrades-goodrx-holdings-to-overweight-announces-10-price-target
Wells Fargo Upgrades GoodRx Holdings to Ov...
03/25/2024 09:21:35

Wells Fargo analyst Stan Berenshteyn upgrades GoodRx Holdings (NASDAQ:GDRX) from Equal-Weight to Overweight and announces $1...

rbc-capital-reiterates-sector-perform-on-goodrx-holdings-maintains-8-price-target
RBC Capital Reiterates Sector Perform on G...
03/08/2024 16:13:39

RBC Capital analyst Sean Dodge reiterates GoodRx Holdings (NASDAQ:GDRX) with a Sector Perform and maintains $8 price target.

wells-fargo-maintains-equal-weight-on-goodrx-holdings-raises-price-target-to-75
Wells Fargo Maintains Equal-Weight on Good...
03/01/2024 18:01:29

Wells Fargo analyst Stan Berenshteyn maintains GoodRx Holdings (NASDAQ:GDRX) with a Equal-Weight and raises the price target...

rbc-capital-maintains-sector-perform-on-goodrx-holdings-raises-price-target-to-8
RBC Capital Maintains Sector Perform on Go...
03/01/2024 15:06:13

RBC Capital analyst Sean Dodge maintains GoodRx Holdings (NASDAQ:GDRX) with a Sector Perform and raises the price target fro...

goldman-sachs-maintains-neutral-on-goodrx-holdings-raises-price-target-to-75
Goldman Sachs Maintains Neutral on GoodRx ...
03/01/2024 14:31:57

Goldman Sachs analyst Eric Sheridan maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and raises the price target from ...

truist-securities-maintains-hold-on-goodrx-holdings-raises-price-target-to-8
Truist Securities Maintains Hold on GoodRx...
03/01/2024 13:30:17

Truist Securities analyst Jailendra Singh maintains GoodRx Holdings (NASDAQ:GDRX) with a Hold and raises the price target fr...

these-analysts-increase-their-forecasts-on-goodrx-following-q4-earnings
These Analysts Increase Their Forecasts On...
03/01/2024 13:23:31

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported upbeat fourth-quarter FY23 results and issued first-quarter revenue guidance abov...

td-cowen-maintains-outperform-on-goodrx-holdings-raises-price-target-to-14
TD Cowen Maintains Outperform on GoodRx Ho...
03/01/2024 13:14:32

TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Outperform and raises the price target from $1...

jp-morgan-upgrades-goodrx-holdings-to-overweight-raises-price-target-to-10
JP Morgan Upgrades GoodRx Holdings to Over...
03/01/2024 11:55:10

JP Morgan analyst Lisa Gill upgrades GoodRx Holdings (NASDAQ:GDRX) from Neutral to Overweight and raises the price target fr...

barclays-maintains-overweight-on-goodrx-holdings-raises-price-target-to-9
Barclays Maintains Overweight on GoodRx Ho...
03/01/2024 11:18:08

Barclays analyst Steve Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and raises the price target from...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION